Abstract
Background
The population in Jiamusi has been reported to have the highest prevalence of colorectal cancer (CRC) in China. The genetic causal-effect for this occurrence among the residents remains unclear. Given the long cold seasons with people wearing more clothes and reduced UV exposure, we aimed to study the association between the vitamin D metabolism-related gene CYP24A1 polymorphism and CRC susceptibility.
Method
A case-control study was conducted that included 168 patients with CRC and 710 age-matched healthy individuals as the control group. Plausible susceptible variations were sought and clinical phenotypic-genotype association analysis was performed.
Results
Overall, two CYP24A1 polymorphisms, rs6013905 AX (P = 0.02, OR = 1.89, 95%CI: 1.09–3.29) and rs2762939 GX (P = 0.02, OR = 1.52, 95%CI: 1.08–2.13) were significantly associated with CRC in the Jiamusi population. In the female group, three CYP24A1 polymorphisms, rs6013905 AX (P = 0.04, OR = 2.59, 95%CI: 1.03–6.49), rs2762939 GX (P = 0.01, OR = 2.35, 95%CI: 1.25–4.42), and rs6068816 GG (P = 0.05, OR = 1.89, 95%CI: 0.99–3.59) carriers were significantly associated with CRC. In clinical phenotypic-genotype analysis, rs6013905 GG (P = 0.05, OR = 4.00, 95%CI: 0.92–17.48) and rs2762939 GX (P = 0.03, OR = 4.87, 95%CI: 1.00–23.69) carriers were significantly associated with poorly differentiated CRC, while CYP24A1 rs6068816 AX was significantly associated with the tumor type (P = 0.02, OR = 2.08, 95%CI: 1.10–3.96) and location (P = 0.04, OR = 2.24, 95%CI: 1.05–4.77).
Conclusion
CYP24A1 gene polymorphism may be a genetic risk factor attributable to the highest prevalence of CRC in Jiamusi people. Individuals with CYP24A1 gene polymorphism may have an increased barrier for vitamin D absorption, thus contributing to the risk of CRC development.
Funder
Natural Science Foundation of China
National Key Research and Development Program of China
Guangxi Natural Science Foundation
Self-funded Scientific Research Project of the health and family planning commission of Guangxi Zhuang Autonomous Region
Beijing Hospital Nova Project
Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences
Publisher
Public Library of Science (PLoS)
Reference28 articles.
1. Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies;N Keum;Nat Rev Gastroenterol Hepatol,2019
2. The cost and burden of cancer in the European Union 1995–2014;B Jönsson;Eur J Cancer,2016
3. Projections of the cost of cancer care in the United States: 2010–2020;AB Mariotto;J Natl Cancer Inst,2011
4. China spends more than 220 billion yuan a year on cancer care, according to the National Cancer Center;Shanghai pharma,2019
5. World Health Organization. Global Cancer Observatory. International Agency for Research on Cancer. 2020. https://gco.iarc.fr/today/data/factsheets/populations/160-china-fact-sheets.pdf
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献